SCA
IMMU

Secor Capital Advisors’s Immunomedics Inc IMMU Stock Holding History

Secor Capital Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-31,135
Closed -$126K – 653
2015
Q2 		$126K Buy
+31,135
New +$127K 0.05% 393

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Secor Capital Advisors's IMMU Position: Q3 2015 in Review

Secor Capital Advisors sold out of Immunomedics Inc (IMMU) in Q3 2015, closing a stake of 31,135 shares — an estimated $126K sold.

Secor Capital Advisors first reported a position in IMMU in Q2 2015 and held it in 1 quarter. The position peaked at $126K in Q2 2015. 79 funds tracked by Wall St. Rank hold IMMU as of Q3 2015.

  • Secor Capital Advisors reported no remaining Immunomedics Inc position as of Q3 2015 after selling out during the quarter.
  • Secor Capital Advisors sold 31,135 Immunomedics Inc shares in Q3 2015, an estimated $126K.
  • Secor Capital Advisors first reported a position in Immunomedics Inc in Q2 2015 and held it in 1 quarter.
  • Secor Capital Advisors's Immunomedics Inc position peaked at $126K in Q2 2015.
  • 79 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2015.

Based on Secor Capital Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.